Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

October 28, 2023 updated by: Gregory Zimet, Indiana University
The purpose of this study was to determine whether messages about 1. relative risk of vaccination vs. other activities and 2. strength of doctor's recommendation influenced parental intention to get own child vaccinated against human papillomavirus (HPV) or Influenza.

Study Overview

Study Type

Interventional

Enrollment (Actual)

1165

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 years of age or older
  • Lives in United States
  • Mother or female legal guardian of at least one child aged 9-13
  • Able to understand English
  • For HPV condition: Target child must not have received any doses of HPV vaccine
  • For Flu condition: Target child must not have received the flu vaccine during the prior flu season

Exclusion Criteria:

  • Under 18 years of age
  • Not mother or female legal guardian of at least one child ages 9-13
  • Not living in United States
  • Not able to understand English and Spanish
  • For HPV condition: Target child had already received at least 1 dose of the HPV vaccine
  • For Flu condition: Target child received the influenza vaccine during the previous flu season

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Arm 1. HPV + Control + Control
HPV is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
Experimental: Arm 2. HPV + Control + Strong
HPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 3. HPV + Control + Disclosure
HPV is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 4. HPV + Safety + Control
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 5. HPV + Safety + Strong
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 6. HPV + Safety + Disclosure
HPV is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
No Intervention: Arm 7. Flu + Control + Control
Flu is target vaccine. No message regarding relative safety of vaccine; Provider provides brief routine recommendation for vaccination.
Experimental: Arm 8. Flu + Control + Strong
Flu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 9. Flu + Control + Disclosure
Flu is target vaccine; No message regarding relative safety of vaccine; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 10. Flu + Safety + Control
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides brief routine recommendation for vaccination.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 11. Flu + Safety + Strong
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.
Experimental: Arm 12. Flu + Safety + Disclosure
Flu is target vaccine; Provider provides message about relative safety of vaccination compared to other common daily activities; Provider provides strong recommendation for vaccination and personal disclosure regarding own child's vaccination history.
There are 12 pairs of messages varying in target vaccination, discussion of relative safety of vaccination, and strength of provider recommendation for vaccination.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Willingness to vaccinate child with target vaccine
Time Frame: During survey administration, at approximately 15 minutes into the survey.
During survey administration, at approximately 15 minutes into the survey.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gregory D Zimet, PhD, Indiana University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

February 3, 2015

First Submitted That Met QC Criteria

February 5, 2015

First Posted (Estimated)

February 6, 2015

Study Record Updates

Last Update Posted (Actual)

October 31, 2023

Last Update Submitted That Met QC Criteria

October 28, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Influenza Vaccines

Clinical Trials on Provider Communication about Vaccination

3
Subscribe